AI system that analyzes retinal images to predict kidney disease risk. Leverages retinal biomarkers to identify patients at elevated risk for progressive kidney disease.
Manufactured by
Mediwhale Inc.
Seoul, South Korea
The first comprehensive AI diagnostic solution Dr. Noon is the first comprehensive AI diagnostic solution to predict cardiovascular, kidney, eye diseases, and biological age through retinal images as a biomarker. Mediwhale is turning simple and effective AI diagnostic solutions into reality, empowering everyone to benefit from preventive healthcare.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Bio Preventive Medicine Co. Ltd.
Taiwan · 5 relevant products
Wuhan Jiule Technology Co., Ltd
China · 1 relevant product
CHECK-EYE
Germany · 1 relevant product
11 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 21 closest product alternatives
Bio Preventive Medicine Co. Ltd. · Taiwan
A predictive diagnostic test that evaluates the risk of progression to end-stage kidney disease in patients with diabetic kidney disease. The test identifies patients at high risk during the critical intervention window to prevent dialysis dependency.
Wuhan Jiule Technology Co., Ltd · China
Risk stratification system for chronic disease identification through continuous health parameter monitoring. Leverages AI algorithms and wearable sensor data for predictive health risk evaluation.
CHECK-EYE · Germany
Specialized diagnostic tool designed to screen for diabetic retinopathy in patients with diabetes mellitus. Utilizes artificial intelligence to detect retinal alterations indicative of disease progression. Provides rapid assessment without the need for dilating drops or specialized ophthalmologic equipment.
18 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products